Lucerno Dynamics, a Mooresville based company, developing systems to detect and quantify the uptake of radiolabeled biomarkers, has raised $950,000 of a $1 million debt offering, according to a regulatory filing.
Lucerno’s investigational technology is intended to let clinicians know if a solid tumor is responding to treatment early in the cycle. The noninvasive device can als o act as a quality control for PET/CT imaging.
The company was founded in 2011. The NC Biotechnology Center awarded Lucerno a $150,000 Small Business Research Loan in February 2014, and in March 2015 provided a $3,000 Industrial Intern award to enable ECU dentistry student Ryan Le, MBA, to help Lucerno develop a business plan for its preclinical cancer research tool.
It disclosed the offering in a filing with the U.S. Securities and Exchange Commission: http://www.sec.gov/Archives/edgar/data/1663432/000114036116047803/xslFormDX01/primary_doc.xml
